International Biotechnology Trust as of Dec. 31, 2018
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 45 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 7.9 | $13M | 255k | 49.92 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.3 | $12M | 90k | 130.11 | |
| Celgene Corporation | 7.0 | $11M | 226k | 50.38 | |
| Gilead Sciences (GILD) | 6.5 | $11M | 213k | 49.15 | |
| Regeneron Pharmaceuticals (REGN) | 5.7 | $9.2M | 31k | 293.30 | |
| Exelixis (EXEL) | 5.7 | $9.1M | 590k | 15.44 | |
| Illumina (ILMN) | 4.9 | $7.9M | 34k | 235.57 | |
| Neurocrine Biosciences (NBIX) | 4.4 | $7.1M | 126k | 56.07 | |
| BioMarin Pharmaceutical (BMRN) | 3.8 | $6.2M | 92k | 66.91 | |
| Ligand Pharmaceuticals In (LGND) | 3.7 | $6.0M | 56k | 106.54 | |
| Alexion Pharmaceuticals | 3.5 | $5.6M | 74k | 76.48 | |
| Kalvista Pharmaceuticals (KALV) | 3.1 | $5.0M | 319k | 15.51 | |
| Halozyme Therapeutics (HALO) | 2.8 | $4.6M | 399k | 11.49 | |
| D Stemline Therapeutics | 2.7 | $4.4M | 586k | 7.45 | |
| Biogen Idec (BIIB) | 2.5 | $4.1M | 17k | 236.16 | |
| Amgen (AMGN) | 2.3 | $3.7M | 24k | 152.92 | |
| ACADIA Pharmaceuticals (ACAD) | 2.2 | $3.6M | 282k | 12.69 | |
| Shire | 2.1 | $3.4M | 25k | 136.72 | |
| Radius Health | 2.1 | $3.4M | 264k | 12.94 | |
| Abiomed | 1.9 | $3.0M | 12k | 255.30 | |
| Zogenix | 1.6 | $2.7M | 93k | 28.59 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $2.4M | 43k | 55.58 | |
| Intersect Ent | 1.3 | $2.1M | 96k | 22.11 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $1.9M | 34k | 57.25 | |
| Seattle Genetics | 1.2 | $1.9M | 43k | 44.47 | |
| Ionis Pharmaceuticals (IONS) | 1.1 | $1.7M | 40k | 42.45 | |
| Nektar Therapeutics (NKTR) | 1.0 | $1.5M | 60k | 25.80 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $1.5M | 17k | 85.71 | |
| Bluebird Bio (BLUE) | 0.8 | $1.3M | 17k | 77.88 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $1.3M | 37k | 36.19 | |
| Sage Therapeutics (SAGE) | 0.8 | $1.2M | 16k | 75.21 | |
| Horizon Pharma | 0.7 | $1.1M | 69k | 15.35 | |
| Sutro Biopharma (STRO) | 0.7 | $1.1M | 147k | 7.17 | |
| Amarin Corporation (AMRN) | 0.5 | $854k | 80k | 10.68 | |
| Globus Med Inc cl a (GMED) | 0.5 | $822k | 24k | 33.97 | |
| Array BioPharma | 0.5 | $811k | 73k | 11.19 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $732k | 9.6k | 76.25 | |
| Fibrogen (FGEN) | 0.4 | $716k | 20k | 36.35 | |
| Spring Bk Pharmaceuticals In | 0.4 | $596k | 73k | 8.16 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $547k | 21k | 26.11 | |
| Sangamo Biosciences (SGMO) | 0.3 | $432k | 48k | 9.00 | |
| Amicus Therapeutics (FOLD) | 0.3 | $440k | 59k | 7.51 | |
| Aerie Pharmaceuticals | 0.3 | $425k | 15k | 28.33 | |
| Portola Pharmaceuticals | 0.2 | $367k | 24k | 15.29 | |
| Spark Therapeutics | 0.2 | $369k | 12k | 30.75 |
